Citalopram hydrobromide and Electroencephalogram abnormal - a phase IV clinical study of FDA data

Summary:

Electroencephalogram abnormal is found among people who take Citalopram hydrobromide, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Citalopram hydrobromide and have Electroencephalogram abnormal. It is created by eHealthMe based on reports of 29,420 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 06, 2022

29,420 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 33 people (0.11%) have Electroencephalogram abnormal.


What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 33,302 Citalopram hydrobromide users for its effectiveness, alternative drugs and more.

What is Electroencephalogram abnormal?

Electroencephalogram abnormal is found to be associated with 1,175 drugs and 682 conditions by eHealthMe.

Number of Citalopram hydrobromide and Electroencephalogram abnormal reports submitted per year:

Could Citalopram hydrobromide cause Electroencephalogram abnormal?

Gender of people who have Electroencephalogram abnormal when taking Citalopram hydrobromide *:

  • female: 65.62 %
  • male: 34.38 %

Age of people who have Electroencephalogram abnormal when taking Citalopram hydrobromide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.57 %
  • 30-39: 10.71 %
  • 40-49: 21.43 %
  • 50-59: 17.86 %
  • 60+: 46.43 %

Common drugs people take besides Citalopram hydrobromide *:

  1. Aspirin: 5 people, 15.15%
  2. Topamax: 4 people, 12.12%
  3. Quetiapine Fumarate: 4 people, 12.12%
  4. Gilenya: 4 people, 12.12%
  5. Cimetidine: 4 people, 12.12%
  6. Ticlopidine Hydrochloride: 4 people, 12.12%
  7. Esomeprazole Magnesium: 4 people, 12.12%
  8. Ursodiol: 3 people, 9.09%
  9. Omeprazole: 3 people, 9.09%
  10. Olanzapine: 3 people, 9.09%

Common side effects people have besides Electroencephalogram abnormal *:

  1. Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 7 people, 21.21%
  2. Blood Glucose Increased: 6 people, 18.18%
  3. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 6 people, 18.18%
  4. Agitation (state of anxiety or nervous excitement): 6 people, 18.18%
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 18.18%
  6. Confusional State: 6 people, 18.18%
  7. High Blood Pressure: 6 people, 18.18%
  8. Haemoglobin Decreased: 6 people, 18.18%
  9. Tremor (trembling or shaking movements in one or more parts of your body): 6 people, 18.18%
  10. Confusion: 5 people, 15.15%

Common conditions people have *:

  1. Gastroduodenal Ulcer: 4 people, 12.12%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 9.09%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 9.09%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 9.09%
  5. Constipation: 3 people, 9.09%
  6. Migraine (headache): 3 people, 9.09%
  7. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 9.09%
  8. Drug Exposure During Pregnancy: 3 people, 9.09%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 6.06%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and have Electroencephalogram abnormal?

Check whether Electroencephalogram abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Citalopram hydrobromide:

Electroencephalogram abnormal treatments and more:

COVID vaccines that are related to Electroencephalogram abnormal:

How severe was Electroencephalogram abnormal and when was it recovered:

Expand to all the drugs that have ingredients of citalopram hydrobromide:

Common drugs associated with Electroencephalogram abnormal:

All the drugs that are associated with Electroencephalogram abnormal:

Common conditions associated with Electroencephalogram abnormal:

All the conditions that are associated with Electroencephalogram abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: